Great Pacific Exports

What Great Pacific Exports does

Great Pacific Exports Pvt Ltd (GPEPL) is a privately held, family-owned pharmaceutical manufacturer headquartered in Navi Mumbai, Maharashtra, India, founded on October 1, 2001, and currently managed by the fourth generation of the Kothari family. The company specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs), with a concentrated focus on highly potent and high-value corticosteroids. Its commercial portfolio comprises 21 marketed corticosteroid APIs—including Beclomethasone Dipropionate, multiple Betamethasone variants, Clobetasol Propionate, Clobetasone Butyrate, Dexamethasone variants, Deflazacort, Fluocinonide, Fluocinolone Acetonide, Hydrocortisone Acetate, Methyl Prednisolone, Mometasone Furoate and its monohydrate, multiple Prednisolone variants, and Triamcinolone Base and Acetonide—manufactured to IP/BP/EP/USP pharmacopoeial specifications, plus 8 products in active development. Operations run from a single 2,500 square meter facility at Plot No. D-5/8 & 5/9, TTC Industrial Area, MIDC, Turbhe (Navi Mumbai), designed and constructed to meet ICH GMP guidelines, equipped with stainless steel and glass-lined reactors ranging from 0.5KL to 2.0KL, a Process Development Lab, a Quality Control and Microbiology Laboratory (HPLC, GC, FTIR, UV spectrophotometer, stability chambers), and environmentally controlled warehousing.

GPEPL generates revenue through three streams: direct API sales via B2B quotation-based pricing, contract manufacturing under loan licensee and vendor arrangements for pharmaceutical companies, and regulatory support services covering WHO GMP and KFDA documentation. The go-to-market is sales-led and relationship-driven, with inquiries handled through website forms, direct phone (+91-22-41550854/88), email ([email protected]), industry events, and a presence on LinkedIn, Twitter, and Facebook. No public price list exists; all pricing flows through quote requests. Customer segments are pharmaceutical formulation companies seeking anti-inflammatory, anti-allergic, antipruritic, and anti-hypertension corticosteroid APIs, served across domestic Indian and international markets (Korea enabled via KFDA certification). Disclosed named customers/partners include Anuh Pharma Ltd., S Kant Chemicals Pvt. Ltd., and Eskay Speciality Chemicals.

The business holds WHO GMP certification (valid through December 25, 2027), Indian GMP Certificate Form 28 (valid through April 16, 2028), KFDA (Korean) approval, ISO 9001, a Written Confirmation Certificate for API exports, and Environmental Clearance from the State Environmental Impact Assessment Authority. Management mentors (Mahendra, Rajesh, and Shrikant Kothari) bring five-plus decades of manufacturing experience spanning textile dyes and pigments into pharmaceutical APIs, providing accumulated technical and quality know-how. The company does not appear to use external institutional capital, has no disclosed parent company or subsidiaries, and operates as a single legal entity in the private limited company form under Maharashtra jurisdiction.

Name

Great Pacific Exports

Legal name

Great Pacific Exports Pvt Ltd.

Website

https://gpepl.co.in

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

251–500 employees

Short description

Great Pacific Exports Pvt Ltd (GPEPL) is a privately held Indian API manufacturer specializing in corticosteroid Active Pharmaceutical Ingredients, serving domestic and international pharmaceutical formulation companies through B2B supply, contract manufacturing, and regulatory support.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients (APIs)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active pharmaceutical ingredients
• Corticosteroid API manufacturing
• Contract pharmaceutical manufacturing
• API process development
• Pharmaceutical intermediates

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. API Sales: Sale of manufactured Active Pharmaceutical Ingredients, specifically Corticosteroids. Products include Beclomethasone Dipropionate, Betamethasone variants, Clobetasol Propionate, Dexamethasone variants, and other corticosteroids for anti-inflammatory and anti-allergic applications.
2. Contract Manufacturing: Custom manufacturing services for pharmaceutical companies as a loan licensee or vendor in their supply chain. Partners receive customized pharmaceutical products meeting their specific requirements.
3. Regulatory Support Services: Support for regulatory filings including current quality requirements documentation and international regulatory compliance (WHO GMP, KFDA).

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Great Pacific Exports Pvt Ltd (GPEPL) manufactures Active Pharmaceutical Ingredients (APIs), with a specialization in corticosteroids, and offers contract manufacturing services to global pharmaceutical formulation companies. The company maintains 21 commercial products plus 8 in its development pipeline, produced at WHO GMP, KFDA, and ISO 9001 certified facilities in Navi Mumbai, India.

Product overview

Great Pacific Exports Pvt Ltd (GPEPL) is a professionally managed pharmaceutical company with over 20 years of experience, specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), with a primary focus on corticosteroids. The company operates as a single unified product portfolio comprising: (1) Commercial corticosteroids APIs including 21 marketed products such as Beclomethasone Dipropionate, Betamethasone variants, Clobetasol Propionate, Dexamethasone Sodium Phosphate, Mometasone Furoate, Prednisolone variants, and Triamcinolone Acetonide; (2) A development pipeline of 8 corticosteroids APIs including Betamethasone, Dexamethasone, Hydrocortisone Hemisuccinate, and Methyl Prednisolone variants; and (3) Contract manufacturing services for APIs and loan licensee partnerships. The company serves both domestic and international pharmaceutical markets, positioning itself as a preferred supplier and contract manufacturing partner for API and formulation companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Corticosteroid Active Pharmaceutical Ingredients

Quantifiable outcome

• 21 corticosteroid products and 8 products under development

Named customers3 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Anuh Pharma Ltd.coreOthersPharmaceutical API customer and business partner. Anuh Pharma is one of the valued customers/partners of Great Pacific Exports, sourcing corticosteroids and other APIs for their formulations.
• S Kant Chemicals Pvt. Ltd.coreOthersChemical and pharmaceutical industry partner sourcing APIs from Great Pacific Exports. Listed as a valued customer and partner.
• Eskay Speciality ChemicalscoreOthersSpecialty chemicals company partnering with Great Pacific Exports for API supply. Listed as a valued customer and partner along with other companies in their network.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Coral Pharmaceutical Ltd. Indian API manufacturer with a meaningful steroid and hormone API portfolio. Comparable niche specialization in corticosteroid chemistry and B2B supply to domestic and export formulators.
• Hovione: Portuguese-headquartered global CDMO and corticosteroid API manufacturer with multiple regulatory certifications (FDA, EMA, PMDA). Comparable in niche specialization, highly potent compound handling, and global pharma customer base.
• Symbiotec Pharmalab Limited: One of the world's largest dedicated corticosteroid API manufacturers, also based in India. Symbiotec is the most directly comparable peer given its near-identical focus on steroid hormones, similar B2B API sales model, and overlapping customer base of global formulators.
• Bal Pharma Limited: Indian API and finished formulation manufacturer with corticosteroid APIs and intermediates in its portfolio. Comparable in API manufacturing footprint, regulatory certifications, and B2B pharma customer focus.
• Dishman Carbogen Amcis: Indian-headquartered API and drug intermediates CDMO with corticosteroid manufacturing capabilities. Comparable as a contract manufacturer and steroid API supplier serving global pharmaceutical customers.
• Farmson Pharmaceutical Gujarat Pvt. Ltd. Indian manufacturer of APIs including corticosteroids and steroid intermediates. Comparable as a competing Indian specialty API manufacturer with global export orientation.
• Anuh Pharma Ltd. An Indian API manufacturer that is itself both a customer of and direct competitor to GPEPL in corticosteroid and non-steroidal APIs. Comparable in scale and product mix, and is publicly named as one of GPEPL's enterprise customers.

Broad incumbents

• Cipla Limited: One of India's largest pharmaceutical companies with a substantial API manufacturing division covering corticosteroids among many other molecules. Overlaps with GPEPL in corticosteroid APIs but operates as a broad-based pharma giant rather than a niche specialist.
• Aurobindo Pharma Limited: Major Indian pharmaceutical company with significant in-house API manufacturing across many therapeutic classes including corticosteroids. Broad incumbent with overlapping API capabilities but vastly larger scale and product breadth.

Others

• S Kant Chemicals Pvt. Ltd. Indian specialty chemicals company listed as a GPEPL customer/partner. Operates in adjacent pharmaceutical and chemical intermediates space, providing a customer-side view of GPEPL's downstream value chain rather than direct competition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/great-pacific-exports-pvt-ltd

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Great Pacific Exports